secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001104659-25-058888
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences prices $2.6M public offering of 1.05M shares at $2.50 each
-------------------------------------------------------------------------------

- Offering of 1,054,604 shares closed on June 9, 2025; gross proceeds ~$2.6M.
- Proceeds to fund general corporate purposes, including expenses for Vyome merger and asset sale to Ninjour.
- Maxim Group LLC acted as sole placement agent; receives 7% cash fee and warrants for 52,730 shares at $2.75.
- Shares sold at $2.50 per share; shelf registration filed May 2025 and declared effective May 14, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925058888/0001104659-25-058888-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925058888/tm2517509d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-058888

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer